Human Resources
A Voice for health equity: Organon and J&J leaders champion the Voice to Parliament as a catalyst for change
Human Resources: In a thought-provoking interview with Health Industry Hub, industry leaders from the pharma and medtech sectors shed light on the significance of the Voice to Parliament in closing the gap in health equity for Aboriginal and Torres Strait Islander peoples.
With the upcoming referendum on the Voice to Parliament, Meshlin Khouri, Associate Director of Policy and Communications at Organon and Deborah Guion, Head of Global Community Impact at Johnson & Jonson expressed their organisations’ commitment to educating and raising awareness among their employees about the referendum and its potential implications. They recognised the historic nature of this moment and acknowledged the Voice to Parliament as a critical step towards reconciliation and creating a more inclusive nation.
In addressing some of the misconceptions and myths surrounding the Voice to Parliament, Deb and Meshlin highlighted the importance of engaging in open and respectful dialogue with individuals who may hold different perspectives. They emphasised the need for active listening and understanding to address concerns and dispel myths surrounding the referendum.
Meshlin stressed the importance of addressing existing healthcare inequities, particularly for women, and how the Uluru statement from the Heart aligns with Organon’s commitment to inclusivity and addressing disparities.
Deb emphasised that as corporate citizens, Johnson & Johnson has a responsibility to equip their workforce with the necessary knowledge to make informed choices. Understanding the history, significance, and potential impact of the Voice, will contribute to a more equitable and inclusive healthcare system.
As the conversation drew to a close, both health leaders highlighted the significance of this moment in the nation’s history and the need for active participation and informed choices from all.
In reimagining healthcare, Health Industry HubTM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
Digital & Innovation
Cybersecurity tops investment priorities for ANZ companies
Digital & Innovation: Cybersecurity remains the top technology investment for Australian and New Zealand (ANZ) companies, with a striking 88% […]
MoreNews & Trends - Pharmaceuticals
Novo Nordisk and Lilly’s GLP-1 agonists show promise in type 1 diabetes
Pharma News: GLP-1 receptor agonists lead to significant weight loss and improve blood sugar control in individuals with type 1 […]
MoreNews & Trends - MedTech & Diagnostics
Health Department’s proposed reporting rules face industry pushback over costs and confidentiality
MedTech News: The Department of Health has unveiled stakeholder feedback on the reporting requirements for the Prescribed List (PL), sparking […]
MoreNews & Trends - MedTech & Diagnostics
Threat to innovation: Health Department’s PL reforms spark industry backlash
MedTech News: The Department of Health has unveiled stakeholder feedback on the alignment of charges for supplying medical devices with […]
More